These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Simple demonstration of diabetic microangiopathy]. Müller R Hippokrates; 1970 Sep; 41(3):413. PubMed ID: 5473627 [No Abstract] [Full Text] [Related]
45. Preventing diabetic complications: a primary care perspective. Zimmet P Diabetes Res Clin Pract; 2009 May; 84(2):107-16. PubMed ID: 19278746 [TBL] [Abstract][Full Text] [Related]
46. [Late complications of diabetes--can we prevent them?]. Kappeler H Schweiz Rundsch Med Prax; 1988 Mar; 77(9):222-9. PubMed ID: 3363266 [No Abstract] [Full Text] [Related]
47. The ultrastructure of capillaries of South African diabetics. II. Muscle capillaries. Yodaiken RE; Seftel HC; Lillenstein M; Kew MC; Ipp E Diabetes; 1968; 17():303. PubMed ID: 5651722 [No Abstract] [Full Text] [Related]
49. Diabetes control and complications. Where do we go from here? Ratner RE Online J Curr Clin Trials; 1993 Jun; Doc No 68():[996 words; 6 paragraphs]. PubMed ID: 8313018 [No Abstract] [Full Text] [Related]
50. [Significance of changes in blood serum hexosamines in the pathogenesis of diabetic microangiopathies]. Riabchuk OG; Starosel'tseva LK Sov Med; 1970 Mar; 33(3):21-4. PubMed ID: 5419171 [No Abstract] [Full Text] [Related]
51. Relation of diabetic control to development of microvascular complications. Tchobroutsky G Diabetologia; 1978 Sep; 15(3):143-52. PubMed ID: 359393 [No Abstract] [Full Text] [Related]
52. Natural history of diabetic microangiopathies. Deckert T Tohoku J Exp Med; 1983 Dec; 141 Suppl():319-24. PubMed ID: 6680503 [No Abstract] [Full Text] [Related]
53. Acute diabetic capillaropathy. Tabuenca Del Barrio L; Mozo Cuadrado M; Compains Silva E; Plaza Ramos P; Andrés Sesma C J Fr Ophtalmol; 2020 Jan; 43(1):101-102. PubMed ID: 31882251 [No Abstract] [Full Text] [Related]
54. Diabetic microangiopathy in KK mice. V. Effect of early glyburide treatment of kidney glucosyltransferase activity. Reddi AS; Oppermann W; Velasco C; Camerini-Davalos RA Exp Mol Pathol; 1978 Dec; 29(3):442-7. PubMed ID: 102528 [No Abstract] [Full Text] [Related]
55. [Diabetic glomerulosclerosis (a review of the literature)]. Bodnar PN Vrach Delo; 1976 Jan; (1):93-7. PubMed ID: 1108443 [No Abstract] [Full Text] [Related]
56. Intervention in diabetic vascular disease by modulation of growth factors. Serri O; Renier G Metabolism; 1995 Oct; 44(10 Suppl 4):83-90. PubMed ID: 7476317 [TBL] [Abstract][Full Text] [Related]
57. A clinical study on treatment of vascular complications of diabetes with the sugar--reducing and pulse--invigorating capsule. Lin L; Zhang H; Gao Q; Ma J J Tradit Chin Med; 1994 Mar; 14(1):3-9. PubMed ID: 8196413 [TBL] [Abstract][Full Text] [Related]
58. [Contribution of angioxine to the vascular protection of the diabetic]. Journ Annu Diabetol Hotel Dieu; 1976 May; ():319-27. PubMed ID: 796526 [No Abstract] [Full Text] [Related]
60. [Diabetic microangiopathy. Study of the relationships between the skin biopsy data, age of the patient, type and duration of diabetes]. Romani JD Acta Diabetol Lat; 1972; 9(5):709-28. PubMed ID: 4662387 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]